Skip to content
Inciteful Med

Growing Up (and Growing Older) with Noonan Syndrome: Monitoring and Long-Term Care

Last updated:

Most individuals with Noonan syndrome live full, independent lives with a normal life expectancy. Long-term care requires regular cardiac evaluations, growth monitoring, and neurodevelopmental support, transitioning from pediatric to specialized adult care over time.

Key Takeaways

  • • Regular cardiac evaluations, including echocardiograms and EKGs, are essential throughout life for individuals with Noonan syndrome.
  • • Children with Noonan syndrome often benefit from early intervention therapies and specialized educational plans like an IEP or 504 Plan.
  • • Routine blood draws for asymptomatic children to check for JMML are generally not recommended, though pediatricians will monitor for clinical signs.
  • • Adults newly diagnosed with Noonan syndrome should immediately schedule a comprehensive baseline cardiac evaluation and bleeding workup.
  • • Most adults with Noonan syndrome lead independent lives and have a normal life expectancy when they maintain routine medical care.

Noonan syndrome is a lifelong journey that changes as a person grows. While the initial diagnosis can be overwhelming, long-term management is about staying proactive with regular screenings and building a supportive environment for school, daily life, and eventually, adulthood [1][2].

Your Long-Term Surveillance Checklist

Because Noonan syndrome can affect many systems, regular check-ups with different specialists are necessary to catch and manage issues early [3][4].

  • Heart (Cardiology): Periodic echocardiograms (ECHO) and EKGs are essential, even if previous scans were normal [5][6]. The frequency will depend on your specific heart findings and genetic mutation [7][8].
  • Growth (Endocrinology): Regular height and weight checks help determine if growth hormone therapy is needed [9][10]. Bone age and hormone levels (like IGF-1) are also monitored [11].
  • Vision and Hearing: Screening for issues like strabismus (crossed eyes) and hearing loss should happen regularly throughout childhood [12][13].
  • Blood (Hematology): Because of the very small risk of JMML in early childhood (primarily with PTPN11), your pediatrician will monitor for clinical signs during regular exams, such as an enlarged spleen, unexplained bruising, or paleness [14]. Current medical guidelines generally advise against routine blood draws (CBC) for asymptomatic children to avoid unnecessary distress and medicalization [15].

Supporting Development and School

Many individuals with Noonan syndrome face neurodevelopmental challenges, such as ADHD, autism spectrum disorder (ASD), or mild learning delays [16][17].

  • Early Intervention: Physical, occupational, and speech therapy can be very helpful in meeting early milestones [18][19].
  • Educational Plans: Most students with Noonan syndrome benefit from an Individualized Education Program (IEP) or a 504 Plan [17][20]. These plans provide accommodations such as extra time on tests, speech therapy in school, or specialized seating to help with attention or physical needs [20].

Adults Diagnosed Later in Life

Because Noonan syndrome features can be subtle, many individuals are only diagnosed in adulthood—often after their child is diagnosed [21]. If you are an adult newly diagnosed with NS:

  • Immediate Steps: Schedule a comprehensive baseline cardiac evaluation (ECHO and EKG) with an adult cardiologist familiar with congenital heart disease [22].
  • Ongoing Care: Heart conditions like hypertrophic cardiomyopathy can still develop or progress later in life [7]. You should also have a bleeding workup before any surgeries or major dental work [23].
  • Prognosis: The long-term outlook for adults with Noonan syndrome is generally excellent. Most adults live typical, independent lives and have a normal life expectancy, provided they maintain regular cardiac check-ups [24].

Transitioning to Adulthood

For teens growing up with NS, care needs to eventually transition from pediatric to adult specialists [25]. Discussions about the transition should ideally begin in the early teen years [25]. It is important to find adult cardiologists and primary care doctors who understand the long-term risks of RASopathies [22].

Quality of Life

Most individuals with Noonan syndrome lead full, independent lives [24][26]. While the condition requires more medical appointments than average, staying on top of screenings and securing the right support helps ensure that the focus remains on the person, not just the diagnosis [16][27]. Your medical team is there to help you navigate each new chapter as it comes [28].

Return to Home Page

Frequently Asked Questions

What medical screenings are needed long-term for Noonan syndrome?
Individuals with Noonan syndrome need regular check-ups, including echocardiograms and EKGs for heart health, growth monitoring, and vision and hearing tests. Your doctor will create a specific surveillance checklist based on your genetics and symptoms.
How does Noonan syndrome affect learning and school?
Children with Noonan syndrome may experience ADHD, autism spectrum disorder, or mild learning delays. Many benefit from Individualized Education Programs (IEPs) or 504 Plans to provide accommodations like extra test time or speech therapy.
What should I do if I am diagnosed with Noonan syndrome as an adult?
Adults newly diagnosed with Noonan syndrome should schedule a comprehensive baseline cardiac evaluation, including an ECHO and EKG. It is also important to have a bleeding workup before undergoing any surgeries or major dental work.
What is the life expectancy for someone with Noonan syndrome?
The long-term outlook is generally excellent. Most adults with Noonan syndrome live typical, independent lives and have a normal life expectancy, provided they maintain regular cardiac check-ups and medical care.
When should a teen with Noonan syndrome switch to adult doctors?
Discussions about transitioning from pediatric to adult specialists should begin in the early teen years. It is important to find adult cardiologists and primary care doctors who understand the long-term risks of the condition.

Questions for Your Doctor

  • • Can we create a written 'surveillance checklist' that summarizes all the screenings (heart, eyes, hearing, etc.) we need and how often?
  • • What are the first signs of ADHD or learning challenges I should look for as my child starts school?
  • • At what age should we start discussing the transition from pediatric to adult specialists (like moving from a pediatric to an adult cardiologist)?
  • • Can you provide a 'medical summary' letter for us to share with the school to help secure an IEP or 504 plan?
  • • As an adult diagnosed with Noonan syndrome, what specific baseline tests do I need right away?

Questions for You

  • • Do I feel like I have a clear 'road map' for the next few years of medical care?
  • • Which area—school, heart health, or growth—feels like the biggest priority for our family right now?
  • • What are my child's (or my) greatest strengths, and how can we use them to navigate medical challenges?
  • • As I/my child get older, how can I encourage more independence in managing this condition?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.

    Linglart L, Gelb BD

    American journal of medical genetics. Part C, Seminars in medical genetics 2020; (184(1)):73-80 doi:10.1002/ajmg.c.31765.

    PMID: 32022400
  2. 2

    Noonan syndrome - a new survey.

    Tafazoli A, Eshraghi P, Koleti ZK, Abbaszadegan M

    Archives of medical science : AMS 2017; (13(1)):215-222 doi:10.5114/aoms.2017.64720.

    PMID: 28144274
  3. 3

    Impact of pubertal timing on growth progression and final height in subjects affected by RASopathies.

    Tamburrino F, Mazzanti L, Gibertoni D, et al.

    Frontiers in endocrinology 2024; (15()):1531545 doi:10.3389/fendo.2024.1531545.

    PMID: 39897954
  4. 4

    Novel characterization of MRAS mutation-associated Noonan syndrome: Mild adult-onset hypertrophic cardiomyopathy combined with infective endocarditis: A case report.

    Mou X, Liu Y, Zhang Y, et al.

    Medicine 2026; (105(2)):e46340 doi:10.1097/MD.0000000000046340.

    PMID: 41517739
  5. 5

    Noonan Syndrome Growth Charts and Genotypes: 15-Year Longitudinal Single-Centre Study.

    Cappa M, Cappa M, d'Aniello F, et al.

    Hormone research in paediatrics 2025; (98(6)):655-667 doi:10.1159/000540092.

    PMID: 38964306
  6. 6

    The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome.

    Koh AL, Tan ES, Brett MS, et al.

    Molecular genetics & genomic medicine 2019; (7(4)):e00581 doi:10.1002/mgg3.581.

    PMID: 30784236
  7. 7

    Cardiac Manifestations of Noonan Syndrome.

    Karnik R, Geiger M

    Pediatric endocrinology reviews : PER 2019; (16(Suppl 2)):471-476 doi:10.17458/per.vol16.2019.kpg.manifestationsnoonan.

    PMID: 31115199
  8. 8

    Cardiac features of Noonan syndrome in Japanese patients.

    Ichikawa Y, Kuroda H, Ikegawa T, et al.

    Cardiology in the young 2023; (33(4)):564-569 doi:10.1017/S104795112200124X.

    PMID: 35475426
  9. 9

    Noonan syndrome and Noonan-like syndrome with loose anagen hair: rare phenotypes may emerge during follow-up.

    Liu Z, Lai J, Song F

    Translational pediatrics 2024; (13(7)):1161-1168 doi:10.21037/tp-24-113.

    PMID: 39144424
  10. 10

    Case report: A de novo RASopathy-causing SHOC2 variant in a Chinese girl with noonan syndrome-like with loose anagen hair.

    Wang Q, Cheng S, Fu Y, Yuan H

    Frontiers in genetics 2022; (13()):1040124 doi:10.3389/fgene.2022.1040124.

    PMID: 36579329
  11. 11

    Management strategies for optimal linear growth in Noonan syndrome (NS) children: minireview and case series of three patients with NS due to PTPN11 mutation and confirmed growth hormone deficiency.

    Kowalik D, Lewiński A, Stawerska R

    Endokrynologia Polska 2024; (75(6)):592-603 doi:10.5603/ep.101588.

    PMID: 40091322
  12. 12

    Cleft palate and hypopituitarism in a patient with Noonan-like syndrome with loose anagen hair-1.

    Couser NL, Keelean-Fuller D, Davenport ML, et al.

    American journal of medical genetics. Part A 2018; (176(9)):2024-2027 doi:10.1002/ajmg.a.40432.

    PMID: 30240112
  13. 13

    Cochlear implantation and clinical features in patients with Noonan syndrome and Noonan syndrome with multiple lentigines caused by a mutation in PTPN11.

    van Nierop JWI, van Trier DC, van der Burgt I, et al.

    International journal of pediatric otorhinolaryngology 2017; (97()):228-234 doi:10.1016/j.ijporl.2017.04.024.

    PMID: 28483241
  14. 14

    Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

    Locatelli F, Algeri M, Merli P, Strocchio L

    Expert review of hematology 2018; (11(2)):129-143 doi:10.1080/17474086.2018.1421937.

    PMID: 29279013
  15. 15

    Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.

    Lasho T, Patnaik MM

    Best practice & research. Clinical haematology 2020; (33(2)):101171 doi:10.1016/j.beha.2020.101171.

    PMID: 32460983
  16. 16

    Prevalence of neurodevelopmental and psychiatric disorders in Noonan syndrome: a systematic review and meta-analysis.

    Pascual-Morena C, Martínez-García I, Lucerón-Lucas-Torres M, et al.

    European journal of pediatrics 2025; (184(12)):800 doi:10.1007/s00431-025-06648-x.

    PMID: 41310115
  17. 17

    Epilepsy in a cohort of children with Noonan syndrome and related disorders.

    Davico C, D'Alessandro R, Borgogno M, et al.

    European journal of pediatrics 2022; (181(8)):2919-2926 doi:10.1007/s00431-022-04497-6.

    PMID: 35575813
  18. 18

    Juvenile xanthogranuloma in Noonan syndrome.

    Ali MM, Gilliam AE, Ruben BS, et al.

    American journal of medical genetics. Part A 2021; (185(10)):3048-3052 doi:10.1002/ajmg.a.62353.

    PMID: 34032360
  19. 19

    Neuropsychiatric phenotypes in children with Noonan syndrome.

    Naylor PE, Bruno JL, Shrestha SB, et al.

    Developmental medicine and child neurology 2023; (65(11)):1520-1529 doi:10.1111/dmcn.15627.

    PMID: 37130201
  20. 20

    Predictors of Receipt of School Services in a National Sample of Youth With ADHD.

    DuPaul GJ, Chronis-Tuscano A, Danielson ML, Visser SN

    Journal of attention disorders 2019; (23(11)):1303-1319 doi:10.1177/1087054718816169.

    PMID: 30526188
  21. 21

    Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.

    Chinton J, Huckstadt V, Moresco A, et al.

    Archivos argentinos de pediatria 2019; (117(5)):330-337 doi:10.5546/aap.2019.eng.330.

    PMID: 31560489
  22. 22

    Management of cardiac aspects in children with Noonan syndrome - results from a European clinical practice survey among paediatric cardiologists.

    Wolf CM, Zenker M, Burkitt-Wright E, et al.

    European journal of medical genetics 2022; (65(1)):104372 doi:10.1016/j.ejmg.2021.104372.

    PMID: 34757052
  23. 23

    Bleeding phenotype and hemostatic evaluation by thrombin generation in children with Noonan syndrome: A prospective study.

    Barg AA, Yeshayahu Y, Avishai E, et al.

    Pediatric blood & cancer 2024; (71(2)):e30761 doi:10.1002/pbc.30761.

    PMID: 37974388
  24. 24

    Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results.

    Calcagni G, Limongelli G, D'Ambrosio A, et al.

    International journal of cardiology 2017; (245()):92-98 doi:10.1016/j.ijcard.2017.07.068.

    PMID: 28768581
  25. 25

    Measuring health care transition: Across time and into the future.

    Cheak-Zamora N, Betz C, Mandy T

    Journal of pediatric nursing 2022; (64()):91-101 doi:10.1016/j.pedn.2022.02.018.

    PMID: 35248956
  26. 26

    Data on cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results.

    Calcagni G, Limongelli G, D'Ambrosio A, et al.

    Data in brief 2018; (16()):649-654 doi:10.1016/j.dib.2017.11.085.

    PMID: 29541661
  27. 27

    Neurological features of Noonan syndrome and related RASopathies: Pain and nerve enlargement characterized by nerve ultrasound.

    De Ridder W, van Engelen B, van Alfen N

    American journal of medical genetics. Part A 2022; (188(6)):1801-1807 doi:10.1002/ajmg.a.62714.

    PMID: 35258168
  28. 28

    A genotype-first approach to exploring Mendelian cardiovascular traits with clear external manifestations.

    Wenger BM, Patel N, Lui M, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(1)):94-102 doi:10.1038/s41436-020-00973-2.

    PMID: 32989268

This page provides educational information about long-term care for Noonan syndrome. Always consult your healthcare team for personalized medical advice and specific screening guidelines.

Stay up to date

Get notified when new research about Noonan syndrome is published.

No spam. Unsubscribe anytime.